Phosphoinositide 3-kinase p110d/p85a Human Recombinant ( PI3Kd Human )

Catalog # PT_41756

Print

$373.00
DescriptionThe class IA PI3K? is expressed in endothelial and in white blood cells. Recently it was shown that the inactivation of PI3K? in bone marrow mast cells (BBMCs) leads to defective stem cell factor-mediated proliferation, adhesion and
Product Size: 1ug
Quantity

Data sheet

Formulation
PI3Kd solution in 25mM Tris-HCl, pH 8.0, 50mM NaCl, 0.5mM MgCl2, and 50% glycerol.
Purity
Greater than 95.0% as determined by SDS Page.
Description
The class IA PI3Kd is expressed in endothelial and in white blood cells. Recently it was shown that the inactivation of PI3Kd in bone marrow mast cells (BBMCs) leads to defective stem cell factor-mediated proliferation, adhesion and migration of these cel
Expression host
Sf9 insect cells.
Synonyms
Phosphoinositide 3-kinase p110d/p85a, PI3Kd.
Reagent Appearance
Sterile filtered liquid formualtion.
Stability
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.
Unit Definition
1 unit is defined as 1 picomole phosphate transferred to PIP2 per minute.
Activity
3,000 U/mg.
New